Acuvue contact lens ads reconfigured by Johnson & Johnson in wake of FDA warning letter.
This article was originally published in The Gray Sheet
Executive Summary
JOHNSON & JOHNSON REFORMULATING ACUVUE CONTACT LENS ADVERTISING CAMPAIGN in order to correct problems outlined by FDA in an Oct. 7 warning letter to the company's Vistakon vision products division. In its letter, the agency asserts that J&J's television and print ads for Acuvue ultraviolet-absorbing Daily Wear and Extended Wear lenses are "misleading" because they imply the products "provide full protection to the eye in environments where protection from UV radiation may be warranted."
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.